Streamline Health merger converts shares to $5.34; warrants canceled for no consideration

Rhea-AI Filing Summary

Matthew Etheridge, a director of Streamline Health Solutions, reported dispositions tied to a merger that took effect on 08/12/2025. Under the Merger Agreement dated May 29, 2025, the company became a wholly owned subsidiary of Mist Holding Co., and each outstanding share of Streamline common stock was canceled and converted into the right to receive $5.34 in cash per share. The filing notes numbers were adjusted for a 1-for-15 reverse stock split effected on October 4, 2024.

The Form 4 shows Mr. Etheridge disposed of 30,876 common shares resulting in 0 common shares beneficially owned following the transaction. It also reports 61,403 underlying shares from Company warrants (exercise price listed as $5.85) that were canceled; warrants with exercise prices equal to or above the merger consideration were canceled for no consideration.

Positive

• Merger consideration of $5.34 per common share provides a cash exit for shareholders
• Transaction effective date (08/12/2025) and reporting show the merger and conversion were completed

Negative

• 61,403 warrant-based shares were canceled; warrants with a $5.85 exercise price were canceled for no consideration
• Reporting person’s beneficial ownership of common stock and warrants is shown as 0 following the transaction, indicating loss of ongoing equity stake

Insights

Securities Analyst

TL;DR: Form 4 documents a merger closing that converted common shares to $5.34 cash and canceled certain warrants.

The filing confirms the Merger Agreement became effective on 08/12/2025, converting each outstanding share into $5.34 cash and extinguishing public equity. The reported figures — 30,876 common shares disposed and 61,403 warrant-related underlying shares canceled — reflect the post-1-for-15 reverse-split adjusted counts. For holders, common shares received cash consideration while warrants with an exercise price at or above $5.34 were canceled for no consideration, per the agreement. This is a material corporate action that finalizes consideration to holders and ends their equity exposure.

Corporate Governance Expert

TL;DR: Insider Form 4 confirms corporate control change and extinguishment of public equity and certain derivative claims.

The Form 4 provides clear documentation that Streamline Health became a wholly owned subsidiary of the acquirer at the Effective Time, with outstanding common shares canceled for $5.34 per share and certain warrants canceled without payment where the exercise price met or exceeded the merger consideration. The reporting director's beneficial ownership is reduced to zero for both common stock and warrants, evidencing completion of the transaction and transfer of economic rights to the merger consideration. This filing is a definitive, material disclosure about corporate control and investor pay-out mechanics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Etheridge Matthew

(Last) (First) (Middle)

2400 OLD MILTON PARKWAY

BOX 1353

(Street)

ALPHARETTA GA 30009

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STREAMLINE HEALTH SOLUTIONS INC. [ STRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value	08/12/2025		D(1)		30,876	D	(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (right to buy)	$5.85(2)	08/12/2025		D(1)			61,403	(3)	(3)	Common Stock, $0.01 par value	61,403	(3)	0	D

Explanation of Responses:

1. This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration").

2. The Issuer effected a 1-for-15 reverse stock split of its common stock on October 4, 2024. The number of securities reported on this Form 4 has been adjusted to reflect the reverse stock split.

3. Pursuant to the terms of the Merger Agreement, at the Effective Time, each warrant to purchase shares of Common Stock (each, a "Company Warrant") that was outstanding and unexercised and had a per share exercise price that was less than the Merger Consideration was canceled and converted into the right to receive (i) a cash payment equal to (A) the number of shares of Common Stock subject to the Company Warrant immediately prior to the Effective Time multiplied by (B) the excess, if any, of (x) the Merger Consideration over (y) the exercise price per share of Common Stock of such Company Warrant, less applicable withholding taxes. Each Company Warrant that was outstanding and unexercised with a per share exercise price that was equal to or greater than the Merger Consideration was canceled for no consideration.

	/s/ Matthew Etheridge	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for STRM report on 08/12/2025?

The Form 4 reports that common shares were converted into the right to receive $5.34 per share under the Merger Agreement effective 08/12/2025, and certain warrants were canceled.

How many Streamline common shares did Matthew Etheridge dispose of?

The filing reports disposition of 30,876 common shares, with 0 common shares beneficially owned following the transaction.

What happened to Streamline warrants held by the reporting person?

The Form 4 shows warrants covering 61,403 underlying shares; warrants with an exercise price of $5.85 were canceled per the Merger Agreement, and the reporting person holds 0 thereafter.

Was there a stock split adjustment noted in the filing?

Yes. The issuer effected a 1-for-15 reverse stock split on October 4, 2024, and the numbers on the Form 4 were adjusted accordingly.

What agreement governed the conversions and cancellations described in the Form 4?

The transactions were governed by the Agreement and Plan of Merger dated May 29, 2025, among the issuer, Mist Holding Co., and MD BE Merger Sub, Inc.